In this enlightening episode, we welcome Dr. Kathy MacLaughlin, an Associate Professor of Family Medicine at the Mayo Clinic, to discuss the transformative potential of self-collection for cervical cancer screening. Dr. MacLaughlin explains how this innovative method differs from traditional screening processes and shares the latest FDA-approved options available to patients. We review the current research, examining the accuracy and effectiveness of self-collection through large-scale studies and its successful implementation in other countries. The conversation also highlights the public health implications, including how self-collection can empower individuals, enhance access to screening in underserved areas, and ultimately reduce cervical cancer rates. Join us as we explore the future of cervical cancer screening and the critical role of community engagement in promoting this life-saving approach. Did you connect with this episode? Share your thoughts with us on social media using #CervivorPodcast or by ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠emailing us.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠   For more Cervivor-related content, check out: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Cervivor.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Follow Cervivor on all social media platforms. If you would like to be interviewed as a potential guest for an upcoming episode or would like to request a speaker or topic for a future podcast episode, email us at info@cervivor.org. More About The Guest: Dr. Kathy MacLaughlin is an Associate Professor of Family Medicine at Mayo Clinic with a passion for cervical cancer elimination. She co-chairs the HPV Self-Collection work group for the American Cancer Society National Roundtable on Cervical Cancer and previously co-chaired the IT/EHR group for their Primary HPV Screening Initiative. She has served as a subject matter expert for NORC in their work with the Federal Cervical Cancer Collaborative on the Cervical Cancer Moonshot℠ Roundtable Series and with HRSA’s Office of Women’s Health Cervical Cancer ECHO Learning Series for Safety-Net Settings.